Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for sedation in elderly gastrointestinal endoscopy
ChiCTR2500103917Phase 4Not yet recruiting
- Sponsor
- Jinjiang Municipal Hospital
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine, sufentanil and ciprofol in None (2 arms), sponsored by Jinjiang Municipal Hospital. Primary endpoint: Incidence of hypoxemia in patients. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
oliceridinesufentanilciprofol
Beyond the preview
Go deeper on ChiCTR2500103917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103917.